Reactive oxygen species generation and histamine release by activated mast cells: Modulation by nitric oxide synthase inhibition

British Journal of Pharmacology

Volumn 128, Issue 3, 1999, Pages 585-590

  Brooks, A C ^a   Whelan, C J ^a   Purcell, W M ^b  

^a UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^b UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

Author keywords

Antigen; Nerve growth factor; Neurogenic inflammation; Nitric oxide; Rat peritoneal mast cells; Reactive oxygen species; Substance P

Indexed keywords

COMPOUND 48-80; CYTOKINE; HISTAMINE; N(G) NITROARGININE METHYL ESTER; NERVE GROWTH FACTOR; NITRIC OXIDE SYNTHASE INHIBITOR; OVALBUMIN; REACTIVE OXYGEN METABOLITE; SUBSTANCE P;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HISTAMINE RELEASE; MALE; NONHUMAN; PERITONEUM MAST CELL; PRIORITY JOURNAL; RAT; STIMULATION;

ANIMALS; ENZYME INHIBITORS; HISTAMINE RELEASE; MALE; MAST CELLS; NERVE GROWTH FACTOR; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; OVALBUMIN; P-METHOXY-N-METHYLPHENETHYLAMINE; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SUBSTANCE P;

EID: 0032698012     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702838     Document Type: Article

References (37)

1. ALOE, L., BRACCI, L.L., LAUDIERO, L., BONNINI, S. & MANNI, S. (1997). The expanding role of nerve growth factor: from neurotrophic activity to immunologic diseases. Allergy. 52, 883-994.
2. ANTON, A.H. & SAYRE, D.F. (1969). A modified flurometric procedure for tissue histamine and its distribution in various animals. J. Pharmacol. Exp. Ther., 166, 285-292.
3. BELLO, M.G., MASINI, E., IOANNIDIES, C., NDISANG, J.F., RASPANTI, S., SACCHI, T.B. & MANNAIONI, P.F. (1998). Histamine release from rat mast cells induced by metabolic activation of drugs of abuse into free radicals. Inflammation Res., 47, 122-130.
4. BIDRI, M., KTORZA, S., VOULDOUKIS, I., LE GOFF, L., DEBRE, P., GUILLOSSON, J.J. & AROCK, M. (1997). Nitric oxide pathway is induced by FcεRI and upregulated by stem cell factor in mouse mast cells. Eur. J. Immunol., 27, 2907-2913.
5. BONNI, S., LAMBIASE, A., BONNI, S., ANGELUCCI, F., MAGRINI, L., MANNI, L. & ALOE, L. (1996). Circulating nerve growth factor levels are increased in humans with allergic disorders. Proc. Nat. Acad. Sci. U.S.A., 93, 10955-10960.
6. BROOKS, A.C. & WHELAN, C.J. (1999). Reactive oxygen species generation by mast cells in response to substance P: An NK1-receptor mediated event. Inflammation Res., in press.
7. BROOKS, A.C., WHELAN, C.J. & PURCELL, W.M. (1998). Reactive oxygen species generation by non-immunological mast cell activation: modulation by nitric oxide synthase inhibitors. Br. J. Pharmacol., 124, 4P.
8. CLANCY, R.M., LESZXYNSKA-PIZIAK, J. & ABRAMSON, S.B. (1992). Nitric oxide, an endothelial derived relaxing factor, inhibits neutrophil superoxide anion production via a direct action on NADPH-oxidase. J. Clin. Invest., 90, 1116.
9. CRIVELLATO, E., DAMAIANI, D., MALLARDI, F. & TRAVAN, L. (1991). Suggestive evidence for a microanatomical relationship between mast cells and nerve fibres containing substance P, calcitonin gene related peptide, vasoactive intestinal polypeptide, and somatostatin in the rat mesentery. Acta Anatomica, 141, 127-131.
10. DESCHOOLMEESTER, M.L., EASTMOND, N.C., DEARMAN, R.J., KIMBER, I., BASKETTER, D.A. & COLEMAN, J.W. (1999). Reciprocal effects of interleukin-4 and interferon-γ on immunoglobulin E-mediated mast cell degranulation; a role for nitric oxide but not peroxynitrite or cyclic guanosine monophosphate. Immunology, 96, 138-144.
11. DIMITRIADOU, V., ROLEAU, A., TRUNG-TIONG, M.D., NEWLANDS, N., MILLER, H., LUFFAU, G., SCWARTZ, J. & GARBARG, M. (1997). Functional relationships between sensory nerve fibres and mast cells of the dura matter in normal and inflammatory conditions. Neuroscience, 77, 829-839.
12. EASTMOND, N.C., BANKS, E.M.S. & COLEMAN, J.C. (1997). Nitric oxide inhibits IgE mediated degranulation of mast cells and is principal intermediate in IFN-γ induced suppression of exocytosis. J. Immunol., 159, 1444-1450.
13. FILEP, J., BARON, C., LACHANCE, S., PERREAULT, C. & CHAN, J. (1996). Involvement of nitric oxide in target cell lysis and DNA fragmentation induced by murine natural killer cells. Blood, 87, 5136-5143.
14. FREDERIKS, W.M., BOSCH, K.S. & VREELING-SINDELAROVA, H.A. (1997). In situ detection of constitutive superoxide anion production in granules of mast cells. Histochem. J., 29, 287-291.
15. FUKUISHI, N., SAKAGUCHI, M., MATSUURA, S., NAKAGAWA, C., AKAGI, R. & AKAGI, M. (1997). The mechanisms of compound 48/80-induccd superoxide generation mediated by A-kinase in rat peritoneal mast cells. Biochem. Mol. Med., 61, 107-113.
16. GUSHCHIN, I., PETYAEV, I. & TSINKALOVSKY, O. (1990). Kinetics of oxygen metabolism indices in the course of histamine secretion from rat mast cells. Agents Actions, 30, 85-88.
17. HORIGOME, K., BULLOCK, E.D. & JOHNSON, E.M.J. (1994). Effects of nerve growth factor on rat peritoneal mast cells. J. Biol. Chem., 269, 2695-2702.
18. JANISZEWSKI, J., BIENENSTOCK, J. & BLENNERHASSET, M.G. (1994). Picomolar doses of substance P trigger electrical responses in mast cells without degranulation. Am. J. Physiol., 267, C138-C145.
19. JOHNSON, A.R. & ERDOS, E.G. (1973). Release of histamine from mast cells by vasoactive peptides. Proc. Soc. Exp. Biol., 142, 1252-1256.
20. LANDER, H.M. (1996). Cellular activation mediated by nitric oxide. Methods, 10, 15-20.
21. LAU, H.Y.A. & CHOW, S.M. (1999). Nitric oxide does not affect histamine release from rat peritoneal mast cells. Inflammation Res., 48, S27-S28.
22. LEBEL, C. & BONDY, S. (1990). Sensitive and rapid quantitation of oxygen reactive species formation in rat synaptosomes. Neurochem. Int., 17, 435-440.
23. LIANG, Y., MARCUSSON, J.A., JACOBI, H.H., HAAK-FRENDSCHO, M. & JOHANSSON, O. (1998). Histamine containing mast cells and their relationship to NGFr-immunoreactive nerves in prurigo nodularis: a reappraisal. J. Cutaneous Pathol., 25, 189-198.
24. MAGGI, C.A. (1997). The effects of tachykinins on inflammatory and immune cells. Regul. Peptides, 70, 75-90.
25. MANNAIONI, P.F., MASINI, E., PISTELLI, A., SALVEMINI, D. & VANE, J. (1991). Mast cells as a source of superoxide anions and nitric oxide like factor: relevance to histamine release. Int. J. Tissue React., XIII, 271-278.
26. METCALFE, D.D., BARAM, D. & MEKORI, Y.A. (1997). Mast cells. Physiol. Rev., 77, 1033-1079.
27. NIU, X.F., IBBOTSON, G. & KUBES, P. (1996). A balance between nitric oxide and oxidants regulates mast cell-dependent neutrophil-endothelial cell interactions. Circ. Res., 79, 992-999.
28. PEARCE, F.L. & THOMPSON, H.L. (1986). Some characteristics of histamine secretion from rat peritoneal mast cells stimulated with nerve growth factor. J. Physiol., 372, 379-393.
29. PURCELL, W.M. & ATTERWILL, C.K. (1995). Mast Cells in neuroimmune function: neurotoxicological and neuropharmacological perspectives (a review). Neurochem. Res., 20, 521-532.
30. SALVEMINI, D. & BOTTING, R. (1993). Modulation of platelet function by free radicals and free radical scavengers. Trends Pharmacoal., 14, 36.
31. SALVEMINI, D., MASINI, E., PISTELLI, A., MANNAIONI, P.F. & VANE, J. (1991a). Nitric oxide: a regulatory mediator of mast cell reactivity. J. Cardiovasc. Pharmacol., 17, S258-S264.
32. SALVEMINI, D., PISTELLI, A., MANNAIONI, P.F. & VANE, J. (1991b). Rat mast cells synthesize a nitric oxide like factor which modulates the release of histamine. Agents Actions, 33, 61.
33. SCINETTI, M.L., MAZZINI, A., GRECO, R. & BERETELLI, A. (1984). Effect of levamisole on superoxide production from mast cells. Pharmacol. Res. Commun., 16, 101-107.
34. SUGIMOTO, Y., OHISHI, H., TOYOTA, T. & KAMEI, C. (1998). Strain differences in histamine release from peritoneal mast cells in rats. Gen. Pharmacol., 31, 613-616.
35. UNDERWOOD, S.L., RAEBURN, D., LAWRENCE, L.C., FOSTER, M., WEBBER, S. & KARLSSON, J.A. (1997). RPR106541, a novel airway selective glucocorticoid: effects against antigen-induced CD4 + T lymphocyte accumulation and cytokine gene expression in Brown Norway rat lung. Br. J. Pharmacol., 122, 439-446.
36. VERDON, C., BURTON, B. & PRIOR, R. (1995). Sample pre-treatment with nitrate reductase and glucose-6-phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP - when the Griess reaction is used to assay for nitrate. Anal. Biochem., 224, 502-508.
37. WOLFREYS, K. & OLIVIERA, D. (1997). Alterations in intracellular reactive oxygen species generation and redox potential modulate mast cell function. Eur. J. Immunol., 27, 297-306.